GENE ONLINE|News &
Opinion
Blog

R&D
11-year-old becomes the first recipient of Novartis’s personalized CAR-T therapy
2019-02-01
Single neurons responsible for error detection and adjustment found
2019-01-03
First PARP inhibitor approved for 1L maintenance therapy of BRCAm advanced ovarian cancer
2018-12-28
Roche Announces Analysis of Hemlibra’s Phase III HAVEN 2 Study at ASH meeting
2018-12-21
Gilteritinib becomes first FLT3 targeted therapy for relapsed AML
2018-12-04
Halting C.difficile with first-in-class oral enzyme & microbiome
2018-11-27
The Pioneer of CRISPR Genome Editing ─ Jennifer A. Doudna Visits Taiwan
2018-11-25
Obituary: Arthur Jay Eisenberg (1956-2018)
2018-11-14
Pembrolizumab Upstages Topline PD-1/L1 drugs in lung cancer tussle
2018-11-06
Update on Tuberculosis containment using vaccine – Taming the disease
2018-10-26
M&A
Targeted cancer radiopharma specialist – ENDOCYTE INC.’s acquisition
2018-10-23
Roche’s breast cancer drug, Kadcyla succeeds phase III trial
2018-10-22
Finding new pharmacological approach for neuroblastoma treatment
2018-10-16
Tracking “OFF THE SHELF” CAR-T Cell therapy & an IPO worth $100M
2018-10-15
R&D
A new player emerges in the non-small cell lung cancer (NSCLC) therapy scene
2018-10-11
1 29 30 31 32
LATEST
GeneOnline’s Weekly News Highlights: Nov 20-Nov 24
2023-11-27
SK Bioscience and Hilleman Laboratories Join Forces for Ebola Vaccine Development
2023-11-23
BeiGene to Expand Oncology Pipeline Through ENSEM Therapeutics Partnership
2023-11-23
Advancing the Frontiers of Cell and Gene Therapy – An Interview with Dr. Shin Kawamata
2023-11-21
Astellas and Pfizer’s Drug Receives FDA Approval as Treatment for High-Risk Prostate Cancer Recurrence
2023-11-21
GeneOnline’s Weekly News Highlights: Nov 13-Nov 17
2023-11-20
Singapore’s NUS Medicine Launches Centre for Sustainable Medicine
2023-11-20
EVENT
2023-11-30
2023 Healthcare+ EXPO・Taiwan
Taipei , Taiwan
Scroll to Top